ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
67 036,99
0,14%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Invivyd Inc (IVVD)

  7. Invivyd Inc (IVVD) Actualités

IVVD Invivyd Inc

2,40
-0,05 (-2,04%)
18 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Invivyd Inc IVVD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,05 -2,04% 2,40 00:32:52
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,40 2,37 2,45 2,40 2,45
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/5/202422:11EDGAR2Form 144 - Report of proposed sale of securities
13/5/202422:01GLOBEInvivyd to Participate at the H.C. Wainwright 2nd Annual..
09/5/202422:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:08EDGAR2Form 8-K - Current report
09/5/202422:01GLOBEInvivyd Reports First Quarter 2024 Financial Results and..
07/5/202413:38EDGAR2Form 8-K - Current report
07/5/202413:30GLOBEInvivyd to Pursue Rapid Immunobridging Pathway to Potential..
02/5/202423:13GLOBEInvivyd to Host Conference Call Discussing First Quarter..
30/4/202413:30GLOBEInvivyd Announces $20 Million to $25 Million Improvement in..
15/4/202413:30GLOBEInvivyd Receives Healthcare Common Procedure Coding System..
12/4/202413:30GLOBEInvivyd Announces CEO Transition
04/4/202422:01GLOBEInvivyd Provides PEMGARDA™ Launch Update and Announces 2024..
28/3/202412:00GLOBEInvivyd Reports Full Year 2023 Financial Results and Recent..
22/3/202420:28GLOBEInvivyd Announces Interim Exploratory Data on VYD222 from..
22/3/202420:04GLOBEInvivyd Announces FDA Authorization for Emergency Use of..
12/2/202422:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202422:47EDGAR2Form S-3 - Registration statement under Securities Act of..
09/2/202422:01EDGAR2Form 8-K - Current report
05/2/202422:02GLOBEInvivyd to Participate at the Guggenheim Healthcare Talks..
26/1/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202413:12EDGAR2Form 8-K - Current report
03/1/202413:06EDGAR2Form 8-K - Current report
03/1/202413:00GLOBEInvivyd Submits Request for Emergency Use Authorization..
22/12/202322:53EDGAR2Form 8-K - Current report
22/12/202322:51EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/12/202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202313:16EDGAR2Form 8-K - Current report
18/12/202313:00GLOBEInvivyd Announces Positive Initial Results from Ongoing..
20/11/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:10EDGAR2Form 8-K - Current report
09/11/202322:01GLOBEInvivyd Reports Third Quarter 2023 Financial Results and..
02/11/202321:01GLOBEInvivyd to Host Conference Call Discussing Third Quarter..
31/10/202321:01GLOBEInvivyd to Participate in Upcoming Investor Conferences
11/9/202313:10EDGAR2Form 8-K - Current report
11/9/202313:00GLOBEInvivyd Announces Dosing of First Participant in CANOPY..
06/9/202313:00GLOBEInvivyd to Participate in Upcoming Investor Conferences
05/9/202313:05EDGAR2Form 8-K - Current report
05/9/202313:00GLOBEInvivyd Appoints William Duke as Chief Financial Officer
10/8/202322:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:04EDGAR2Form 8-K - Current report
10/8/202322:01GLOBEInvivyd Reports Second Quarter 2023 Financial Results and..
03/8/202322:01GLOBEInvivyd to Host Conference Call Discussing Second Quarter..
27/7/202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
IVVD
Invivyd
EU
GECIW
Fonciere De Paris Siic
NASDAQ
GEEXU
Games and Esports Experi...
NASDAQ
AMRH
Ameri
NASDAQ
NMRKV
LSE
79SS
Nationwde. 36
BOV
A1AP34M
Advance Auto Parts
COIN
BWFUSD
BOV
FRGA5L
Frigorifico Araputanga S... PNA
ASX
OGLN
CSE
COP
Copper Ridge Exploration
IDCM
EPMBTC
Extreme Private Masternode
NASDAQ
WMG
Warner Music
LSE
ZW85
Mitsu Hc Cap.28
BMF
MR1N24U24
MR1N24U24 - 07/2024
LSE
63YF
Sg Issuer 23
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés